Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...

Most people regain some of the weight they lost after stopping semaglutide. However, physical activity and a balanced diet may help you keep some weight off. Share on Pinterest LeoPatrizi/Getty ...

Having excess weight or obesity is the leading risk factor for type 2 diabetes. Almost 90% of the 37 million Americans with type 2 diabetes are classified as having excess weight or obesity. If you ...

Monthly prescriptions for obesity medications reached 1.5 million in February 2024, with semaglutide (Wegovy) and tirzepatide (Zepbound) gaining market share as phentermine’s dominance declines A ...

Among various obesity medications, the highest prescription activity was observed for phentermine, semaglutide, and tirzepatide. By February 2024, approximately 0.74, 0.42, and 0.25 million ...

Obesity drug prescriptions rose from 760,000 in July 2017 to 1.51 million in February 2024. Phentermine was the most prescribed obesity drug in February 2024 while Wegovy was searched for the most ...

The operation, led by Leslie Joann Archambault, 49, involved obtaining and filling fraudulent prescriptions for medications such as Adderall, Alprazolam, Hydrocodone, Phentermine, and Tramadol.

Weight gain is common with hypothyroidism (low thyroid function). Even with the best weight loss efforts, people often find they'll shed a few pounds, but suddenly hit a plateau where exercise and ...

A whopping 37 million people in the U.S. have diabetes, and the vast majority—over 90%—have the type 2 variety. These numbers are hardly surprising, given the obesity epidemic and that obesity is a ...